US SB1132 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on March 30 2023 - 25% progression, died in committee
Action: 2023-03-30 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 30 2023 - 25% progression, died in committee
Action: 2023-03-30 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to allow sponsors of certain new drug applications to rely upon investigations conducted in certain foreign countries, and for other purposes.
Title
ADAPT 2.0 Act Accelerated Drug Approval for Prescription Therapies 2.0 Act
Sponsors
Sen. Mike Braun [R-IN] | Sen. Rand Paul [R-KY] |
History
Date | Chamber | Action |
---|---|---|
2023-03-30 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/senate-bill/1132/all-info |
Text | https://www.congress.gov/118/bills/s1132/BILLS-118s1132is.pdf |